Immune Checkpoint Inhibitor-Induced Hemorrhagic Gastritis

Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of several malignancies and may target cytotoxic T-lymphocyte-associated antigen-4, programmed cell death-1, and programmed cell death ligand 1, which work on maintaining peripheral immune tolerance. ICIs inhibit these...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathialagan, Karthik, Tai, Cheng-Hung, Sethi, Samdish, Thomas, Sumi, Loeser, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424893/
https://www.ncbi.nlm.nih.gov/pubmed/37583508
http://dx.doi.org/10.14309/crj.0000000000001128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424893/
https://www.ncbi.nlm.nih.gov/pubmed/37583508
http://dx.doi.org/10.14309/crj.0000000000001128

Ejemplares similares